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Summary
Since their discovery, our understanding of NK cells has evolved from branding them marginal
innate immunity cells to key players in anti-viral and anti-tumor immunity. Importance of NK
cells in control of various viral infections is perhaps best illustrated by the existence of plethora of
viral mechanisms aimed to modulate their function. These mechanisms include not only virally
encoded immunoevasion proteins but also viral miRNA. Moreover, the evidence has been
accumulated supporting the role of viral immunoevasion of NK cells in viral pathogenesis in vivo.
Introduction
NK cells have a prominent role in early virus control. Upon activation NK cells control
infection either through the lysis of infected cells, or by release of antimicrobial cytokines.
This latter function enables them to influence adaptive immune responses as well. NK cells
survey their surroundings through numerous inhibitory and activating receptors – integration
of these signals determines the activity of an NK cell. More recent data indicate that NK
cells may even acquire memory-like function enabling them to respond differently upon
recall challenge [1–3].
Importance of NK cells in control of viral infection is best illustrated by the sheer number of
viral evasion mechanisms. These mechanisms include regulation of apoptosis, interference
with ADCC, modulation of cytokines and chemokines and function of APCs. Even more
numerous are viral techniques dedicated to control of engagement of NK cell receptors. The
viruses can downmodulate ligands for activating NK cell receptors, provide competitors and
surrogates for cellular ligands, interfere with their translation or target the activating
receptors directly.
Despite a remarkable increase in knowledge about relationship between NK cells and
viruses there are still many outstanding issues. In this review we will highlight recent
progress and current understanding of most important viral immunosubversive mechanisms
directed at NK cells with emphasis on receptor – ligand interactions and their impact on
overall immunity.
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1. Direct interactions with NK cells
In the course of viral infection, NK cells play a crucial role during the early times post
infection. Although the most employed viral evasion techniques are indirect, avoiding NK
cell detection, some viruses have opted for a more direct approach and target NK cells per
se. Influenza virus can directly infect human NK cells via clathrin and caveolin dependent
endocytosis and induce apoptosis [4], a finding which was confirmed in vivo [5]. As viral
transmission happens in the first few days post infection, evasion of innate immunity and
especially NK cells is paramount to influenza virus.
Cross-linking of CD81, tetraspanin involved in the regulation of NK cell recruitment, by
recombinant HCV envelope protein E2 alters IFN-γ production and cytotoxic activity of NK
cells [6]. However, in vivo data did not support this finding as E2 failed to crosslink CD81
when it was a part of a virion [7]. More recent in vitro data using HCV viral particles
showed that engagement of NK cell CD81 results in altered cytokine secretion pattern and
reduced antiviral activity [8]. However, only immobilized HCV viral particles were able to
inhibit IFN-γ secretion and therefore it remains to be seen whether these new data will be
corroborated by in vivo findings. Other examples of direct interactions of viruses and NK
cells are mentioned later in the text.
2. Viral functions that promote engagement of inhibitory NK cell receptors
To avoid recognition by MHC I restricted T cells, many viruses downregulate MHC I.
However, the lack of MHC I molecules is quickly detected by NK cells through lack of
engagement of their inhibitory receptors and thus leading to prevalence of activating ones.
But not all MHC I molecules are fit to display peptides to CD8+ T cells and viruses were
quick to exploit this loophole. In addition to selective downmodulation of MHC I molecules,
viruses are also employing MHC surrogates that are not recognized by cytotoxic T
lymphocytes but are able to engage inhibitory NK cell receptors (reviewed in detail in [9])
(Table 1).
Among viruses cytomegaloviruses (CMVs) are masters of MHC I exploitation in order to
avoid both CD8 and NK cell recognition. Murine CMV (MCMV) encodes 3 regulators of
MHC I molecules: m152 which arrests the maturation of MHC molecules at the level of
ERGIC compartment, m06 which redirects MHC I to lysosomes for degradation and m04
which forms a complex with MHC I and actually allows it to reach the cell surface
(reviewed in [10,11]. The current findings about m04 modus operandi and role are pretty
controversial. On one hand it has been shown that m04 can inhibit MHC I presentation [12]
while others report that m04 antagonizes the action of m152 and enhances recognition of
infected cells by virus specific CD8+ T cells [13]. In addition, m04 is essential for
recognition of infected cells by activating Ly49P receptor but only in complex with H2-Dk
molecules [14]. Since Ly49 family of receptors contain both inhibitory and activating
variants which can recognize the same ligand it is plausible that m04 has originally evolved
as immunoevasin directed at inhibitory Ly49 receptors in order to prevent “missing-self”
recognition. Resistance of mice bearing Ly49P receptor could be a consequence of fierce
and ongoing evolutionary battle between viruses and the host where the host currently has
the upper hand.
HCMV encodes several proteins aimed at regulation of MHC I molecules. Peptide loading is
prevented by US6 which binds to TAP, US3 and US10 retain HLA molecules in ER while
US2 and UL11 target HLA-A but not HLA-E for degradation [15]. Although each protein is
able to reduce class I surface expression independently, recently it was shown that US2 and
US3 coordinate their function so that cells co-expressing both proteins are more successful
in MHC I downregulation [16].
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HLA-E molecules in humans and Qa-1 in mouse present only peptides derived from leader
sequence of other MHC I molecules. To account for this HCMV encodes gpUL40 whose
leader sequence is identical to leader sequences of classical MHC I molecules [17,18]. HLA-
E and Qa-1 molecules are ligands of inhibitory CD94/NKG2 family of receptors and by
maintaining the expression of HLA-E NK cell mediated killing is successfully prevented
even in the absence of other MHC I molecules on the infected cell surface. However, HLA-
E molecules are not without controversy as they too can be recognized by activating CD94/
NKG2 receptors in addition to inhibitory variants. In HCMV infected and HCMV and
HIV-1 co-infected patients Guma and colleagues noticed an expansion of NK cells bearing
activating CD94/NKG2C receptors which outnumbered NK cells with inhibitory CD94/
NKG2A variants. By co-culturing NK cells from HCMV infected patients with infected
fibroblasts, it was demonstrated that expansion of CD94/NKG2C+ NK cells is independent
of the UL16, UL18, and UL40 HCMV genes, but was impaired upon infection with a
mutant lacking the US2-11 gene region responsible for MHC class I inhibition [19]. More
recently, similar result was observed in children infected with HCMV which had higher
levels of NKG2C+ cells [20]; moreover percentages of NKG2C+ cells correlated with the
titers of anti-HCMV IgG antibodies. However, the mechanism behind this interesting
phenomenon remained undefined.
Unlike other viruses, flaviviruses upregulate all MHC I alleles indiscriminately which may
be a consequence of nature of flaviviruses when it comes to choosing their host (Fig 1).
Dengue virus upregulates MHC I expression through TAP dependent and TAP independent
mechanisms and this enhanced MHC I expression is associated with increased binding of
inhibitory NK cell receptors and subsequent reduced susceptibility to NK cell lysis [21]. The
role of NK cells in the control of Dengue virus infection is not yet clear and current reports
send conflicting messages. However, strong evolutionary pressure of NK cells on the
Dengue virus is evident in the fact that the virus has opted for upregulation of MHC I in
order to escape NK cell recognition even though this tactic renders it sensitive to CTL lysis.
Viral MHC I Surrogates
In addition to differential regulation of MHC I expression, viruses employ MHC
homologues or surrogates of both classical and non-classical MHC I molecules (Table 1.). A
successful MHC I surrogate must be able to engage inhibitory NK cell receptors while
avoiding to elicit T cell responses. MHC surrogates are perhaps best represented by HCMV
gpUL18 which shares only a moderate sequence homology to MHC I but binds inhibitory
receptor LIR-1 with 1000-fold higher affinity than HLA-E molecules (reviewed in [22].
Although the expression of US6 could negatively regulate gpUL18 due to its high structural
homology to MHC I, gpUL18 restores TAP mediated peptide translocation while preventing
association of other MHC I molecules and TAP [23]. Thus, gpUL18 is a unique immune
evasion protein enabling resistance to both arms of the immune response: it ensures its own
long life on the cell surface while serving as an MHC surrogate and preventing both CD8
and NK cell recognition. However, gpUL18 is also not free of controversy as it can activate
LIR-1 negative NK cells which comprise the majority of NK cell pool (reviewed in [22].
3. Viral functions that prevent engagement of activating NK cell receptors
In addition to inhibitory receptors ensuring “missing-self” recognition and preventing
autoimmunity, NK cells possess a plethora of activating receptors. As viral infection or
transformation poses a stress to the cell, stress molecules appear on the cell surface alerting
NK cells of suspicious behavior. Since “to attack or not to attack” decision relies on the sum
of signals from inhibitory and activating NK cell receptors, it is important for the viruses to
actively prevent engagement of activating receptors to ensure the prevalence of inhibitory
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signals. Such prevention can be achieved by directly targeting the receptors or indirectly by
interfering with ligands.
3.1. Viral interference with NKG2D receptor
NKG2D, one of the best characterized NK receptors, can override inhibitory signals in the
absence of missing-self recognition. It is expressed on a vast majority of NK cells and also
serves as co-stimulatory receptor on CD8+ T cells. Broad range and heterogeneity of
NKG2D ligands exerts a significant selective pressure on viruses. CMVs have developed
multiple strategies for interference with NKG2D-mediated activation of NK cells (Table 2).
MCMV encodes several proteins that negatively regulate NKG2D ligands; m145 affects
surface portion of MULT-1, m152 targets RAE-1 family and H60 is targeted by m155
(reviewed in [10]). Surface portions of H60, MULT-1 and RAE-1ε are additionally
downregulated by m138/fcr-1 [10,24] (Figure 2A). Deletions of either of these genes results
in the enhanced susceptibility of the MCMV infected cells to NK cell control. Not all
RAE-1 isoforms are equally susceptible to MCMV regulation suggesting host escape from
viral immunoevasion [24,25]. Mature form of RAE-1δ is more resistant to MCMV than
RAE-1γ which could be the consequence of the absence of PLWY motif from RAE-1δ as
compared to RAE-1α, β, γ. More recent studies, which have demonstrated direct interactions
between m152 and RAE-1 proteins, also confirmed quantitative differences in binding
depending on particular RAE-1 isoforms [26]. However, the presence or absence of PLWY
motif could not on its own fully explain the differences in affinity of RAE-1 isoforms to
m152.
HCMV employs two different strategies: MICB, ULBP-1 and ULBP-2 are prevented from
reaching the cell surface by UL16 (reviewed in [27], while newly synthesized full-length
MICA is retained in the cis-Golgi by UL142 [28,29]. Very recently crystal structure of
UL16 in complex with MICB revealed that UL16 mimics a central binding motif of
otherwise structurally unrelated NKG2D thus enabling the virus to disable several diverse
NKG2D ligands [30]. In addition to targeting already synthesized proteins, HCMV also
employs miRNA miR-UL-122 which prevents translation of MICB [31]. Although putative
binding site for miR-UL-122 is found in 3′-UTR of MICA, miR-UL-122 does not cause its
significant downregulation. The recognition sequence for miR-UL-122 is conserved among
different MICB alleles. Similar recognition sites are targets for EBV miR-BART2-5p and
KSHV miR-K12-7 [32] [33] (Figure 2B). Therefore an interesting question is why the host
would keep a highly conserved untranslated sequence just for the purpose of viral
immunoevasion. Though not expressed on the cell surface of normal, healthy cells, MICA
and MICB genes are transcribed in all cells [34]. Translation and subsequent appearance of
these proteins on the cell surface is held in check by cellular miRNAs and histone
acetylation. However, infection with HCMV causes displacement of histone acetylases and
induces transcription of MICA and MICB mRNA rising it to the levels that exceed
repression abilities of cellular miRNAs. Thus the host has ensured a mechanism for
recognizing threat and quickly reacting to it without the need for de novo transcription
which was then, in turn, successfully exploited by the viruses.
Finally, zoonotic orthopox viruses, as well as some tumors, employ saturation of the
receptor tactic. By secreting soluble NKG2D ligands they provide competitor for the
receptor [35]. In addition to competition for the receptor, binding of the soluble ligand
results in internalization of the receptor and thus diminished the amount of available
NKG2D receptors even more (Fig 2B). Other examples of viral immunoevasion directed at
NKG2D are listed in table 2.
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3.2. Viral interference with Ly49 receptors
Most Ly49 receptors are inhibitory receptors, recognizing MHC I molecules. To account for
downregulation of MHC I, viruses encode many MHC-like molecules able to engage Ly49
receptors (Table 2). The first such interaction described is that between Ly49H receptor
present in MCMV resistant C57Bl/6 mice and MCMV encoded m157 protein (reviewed in
[27]. Another mouse strain, MA/My, ensures its MCMV resistance through Ly49P receptor
which recognizes H-2Dk-m04 complexes [14]. Wild derived PWK mouse strain contain
Cmv4 locus which confers resistance to MCMV through as of yet undefined receptor and
mechanism (reviewed in [27] (table 2, figure 2C).
Taking all of this into consideration, it will not come as a surprise that the comparison of the
extracellular domains of several activating and inhibitory Ly49 receptors showed extensive
homology indicating that they might have evolved from common ancestral gene. It is very
likely that activating Ly49 and KIR receptors have evolved from inhibitory analogues
through chromosome duplication and genetic recombination complemented by loss of ITIM
[36].
Do these results suggest that CMV was instrumental for the evolution of Ly49? Virus driven
evolution of its hosts on the population level is certainly not unknown and some examples
have already been pointed out in this review. Other examples of virus driven diversification
of receptors include differential expression of an activating KIR3DS1 which leads to a better
control of HIV virus [37], higher IFN-γ and CD107a expression in unstimulated NK cells in
individuals possessing KIR3DS1 gene [38], influence of distinct allelic combinations of the
KIR3DL1 and HLA-B on AIDS progression [39], better clearance of HCV in patients which
possess KIR2DL3 and HLA-C I alleles [40] or resistance to HCV in drug users which, along
with KIR2DL, KIR2DL3 and HLA-C1 molecules also possess activating KIR2DS4 [41] and
others.
What about cross-specificity of virus-specific receptors to other viruses? Could evolutionary
driven virus specific receptors bring advantage to the host during the infection or co-
infection with a different virus? Recent data indicates just that. NK cells of HIV-1 patients
co-infected with HSV-2 showed more efficient degranulation after in vitro stimulation than
NK cells from HIV mono-infected controls [42]. Additionally, differences in viral load
connected to the number of NK cells expressing NKp30, NKp46, KIR3DL1 and KIR3DS1
activating receptors in HIV monoinfected individuals were not observed in HSV-2 co-
infected patients. Obviously, the reaction of NK cells to HSV-2 infection affected NK
mediated immunity to HIV-1.
3.3. Viral interference with NCR-1
Natural cytotoxicity receptors (NCRs) are a group of activating receptors expressed almost
exclusively on NK cells. Humans express 3 NCR receptors – NKp30, NKP44 and NKP46
while mice possess only one – NCR1. Despite intensive research in the recent years, cellular
ligands remain elusive.
The role of NCRs in viral infections is currently best understood for Influenza virus.
Hemagglutinins (HA) of Influenza virus and hemagglutinin-neuraminidase of Sendai virus
are recognized by NKp44 and NKp46 [43,44]. NCR1 knock-out mice are more sensitive to
Influenza virus than their wild-type counterparts [45]. In contrast, recent reports show that
free HA, which is released along with new virions from the infected cells and UV-
inactivated virions can inhibit NK cell cytotoxicity by entering the cell and inducing ζ-chain
degradation in lysosomes [46]. As NKp30 and NKp46 rely on the ζchain for signal
transduction, signalling from these two receptors is efficiently blocked (Table 2).
Importance of NCR receptors in influenza infection is underscored by yet another
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immunoevasion tactic this virus directs against NCRs – modification of HA through
addition of more glycosilation sites resulting in weaker recognition of HA by NKp46 [47].
HA is therefore yet another example of the constant evolutionary battle between viruses and
their hosts – it is essential for the viral entry into the cell, ligand for activating NK cell
receptor and, at the same time, successful inhibitor of the same receptor.
All the viruses implicated in the immunoevasion of NCRs so far can generally be described
as hit-and-run viruses concerned only with temporary immunoevasion in order to ensure
their spread to new hosts. What about viruses that establish latency, such are CMVs?
HCMV tegument protein pp65, similarly to influenza HA, causes dissociation of ζ-chain
from NKp30 and prevents signal transduction [48]. Reduced or defective NCR expression
during HCV or HIV infection is associated with a decrease in NK cell cytotoxicity [49,50]
(Table 2).
3.4. Viral interactions with other NK cell receptors
As our knowledge about NK cell receptors increases, so does our knowledge of new viral
immunoevasive techniques as viruses do not fail to target any receptor (Table 2). Kaposi’s
Sarcoma Herpes Virus (KSHV) encodes a multi-talented immunoevasin – K5. In addition to
targeting NKG2D ligands MICA and MICB, it also downregulates AICL - ligand of
activating NK cell receptor NKp80 [51]. Low passage strains of HCMV encode UL141
which sequesters CD155 (also known as PVR (poliovirus receptor) in the ER. CD155 is a
ligand for activating NK cell receptors CD96 and DNAM-1 (CD226) [52]. As CD226 is
present on almost all NK cells, downregulation of its ligand is a powerful immunoevasion
tactic. Additionally, CD155 is constitutively present on many cells and can therefore cause
activation of NK cells in the absence or when inhibitory signals are diminished. DNAM-1
also recognizes PVRL2 (CD112), while interaction of PVR (CD155) and PVRL2 with
TIGIT can directly inhibit NK cells and indirectly T cells [53].
Future perspectives—Nowadays a multitude of viral immunoevasion techniques
directed at NK cells are known and have been confirmed in vitro and somewhat in vivo.
Recently few studies have suggested that NK cells can even acquire certain type of memory
features [1,2]. If NK cell memory is biologically relevant in control of chronic infections or
reinfections, one would expect that viruses, which have already invested a lot of effort into
NK evasion, would have means to cope with this function of NK cells as well. The
challenging issue is the fact that SCID mice which possess otherwise normal NK cell
response succumb to MCMV infection by generation of escape mutants [54]. In such
situations, the function of specific memory cells is questionable. Although existence of
memory NK cells has a solid experimental background several questions arise. What would
be advantage of such function if we take into account that constitutive frequency of NK cells
with potential to recognize infected cells is high enough to respond without clonal expansion
characteristic for specific T and B cell responses? Perhaps the most difficult challenge for
the viruses is the necessity to simultaneously avoid T cell and NK cell response, the
functions that are sometimes mutually exclusive such as downmodulation of MHC I. In that
context it would be interesting to investigate how the viral immunoevasins impact the
generation of memory NK cells and how this function impacts the T cell response during
chronic/latent viral infections. By using rhesus monkey CMV lacking MHC I inhibitors
US2-11, Hansen and colleagues have recently demonstrated that these viral regulators are
required for viral replication and dissemination during superinfection [55]. Since MHC I
downregulation should sensitize the virus to missing self recognition by NK cells, it is likely
that this function of viral MHC class I inhibitors can be achieved only in concert with other
immunoevasins which simultaneously prevent NK cell activation. These issues require
intensive further studies.
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Figure 1. Viral functions that promote engagement of inhibitory receptors
Normal, healthy cells display MHC I molecules on their cell surface presenting cellular
peptides which are not recognized by CD8+ T cell receptor. MHC I molecules are ligands
for inhibitory NK cell receptors and their expression on the cell surface ensures tolerance
through prevalence of inhibitory signals. In order to avoid detection by CD8+ T cells viruses
may be tempted to downregulate all MHC I molecules from the cell surface. However this
would render them sensitive to NK cells through “missing-self” recognition. Dengue virus
causes upregulation of MHC I molecules thus enforcing inhibition of NK cells but risking
detection by CD8+ T cells. HCMV selectively downregulates MHC I molecules capable of
presenting peptides to CD8+ T cells while leaving HLA-E molecules capable of engaging
inhibitory NK cell receptors. As HLA-E display peptides derived from leader sequences of
other MHC I molecules, HCMV encodes gpUL40 whose leader sequence is similar to leader
sequences of other MHC I molecules for loading into HLA-E. In addition HCMV also
encodes MHC surrogate gpUL18 which is a ligand for inhibitory LIR-1 receptor.
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Figure 2. Examples of viral interference with function of activating NK cell receptors
A) Viral interference with NKG2D receptor. NKG2D ligands are not expressed on healthy
cells, only on those that are stressed, transformed or undergoing infection. Binding of
NKG2D to its ligands can cause NK cell activation even in the presence of inhibitory
signals. MCMV encodes 4 regulators of NKG2D ligands: m145 downmodulates MULT-1,
m152 downmodulates RAE-1 family of molecules, while H60 is targeted by m155.
Additionally, m138 targets H60, MULT-1 and RAE-1ε. EBV, KSHV and HCMV target
MICB by microRNAs. ZPXV produce soluble NKG2D ligands and thus saturate NKG2D
receptors on NK cells. B) Herpesviral regulation of MICB via miRNAs. EBV, KSHV and
HCMV encode microRNA, small RNAs that, after processing and loading into RISC
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complex, bind to 3′-UTR of MICB messenger RNA and prevent efficient translation of
MICB mRNA. C) MCMV interactions with Ly49 receptors. MCMV encodes MHC I
homologue m157 which, in some MCMV sensitive mice serves as a ligand for inhibitory
Ly49I receptor. However, some mouse strains, during the course of the evolution with
MCMV, have developed activating Ly49H receptor capable of recognizing m157. In MA/
My mice resistance is conferred through the recognition of m04/MHC I complexes on the
cell surface. As there is no evolutionary advantage for the virus to develop and keep protein
displayed on the infected cell surface which is recognized by an activating receptor, it is
quite possible that inhibitory Ly49 receptor specific for the m04/MHC I complexes is
waiting to be found.
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Table 1
Viral proteins affecting engagement of inhibitory NK cell receptors
Virus Immunoevasin Target Action References
Regulators of MHC I expression
MCMV m04 MHC I binding to MHC I in the ER and allowing them to reach cell surface [56]
MCMV m06 MHC I targeting MHC I for degradation [57]
MCMV m152 MHC I retention of MHC I in ERGIC compartment [58]
HCMV US2, US11 HLA I differentially targeting MHC I for degradation [59,60]
HCMV US3, US10 HLA I retention of MHC I in ER [61,62]
HCMV US6 HLA I prevention of peptide loading into MHC I molecules [63,64]
HCMV gpUL40 HLA-E providing leader sequence for loading into HLA-E [17]
HIV p24aa14-22a HLA-E stabilization of HLA-E [65]
HIV Nef HLA-A, HLA-B acceleration of HLA-A and B endocytosis [66]
KSHV K3 HLA I endocytosis of all HLA I molecules [67]
KSHV K5 HLA A, HLAB, HLA C endocytosis of HLA-A and HLA-B, HLA-C is affected only weakly [67]
Viral MHC I surrogates
HCMV gpUL18 LIR-1 binding to inhibitory receptor LIR-1 with higher affinity than HLA-E [68,69]
MCMV m144 unknown possible ligand for inhibitory receptors [70]
RCMV RCTL NKR-P1A homologue of Ocil [71]
RCMV ORFr144 unknown unknown [72]
MCV MC080R unknown unknown [73]
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Table 2
Viral proteins affecting engagement of activating NK cell receptors
Virus Immunoevasin Target Action References
Interference with NKG2D receptor
MCMV m138 H60, MULT-1, RAE-1ε interference with endocytic pathways [10,24]
MCMV m145 MULT-1 intracellular retention [10]
MCMV m152 RAE-1 intracellular retention [74]
MCMV m155 H60 intracellular retention [10,75]
HCMV UL16 MICB, ULBP-1, ULBP-2 intracellular retention [76,77]
HCMV UL142 MICA downregulation of full-length MICA [28,29]
HCMV miR-UL-122 MICB interference with translation [31]
EBV miR-BART2-5p MICB interference with translation [33]
KSHV miR-K12-7 MICB interference with translation [33]
KSHV K5 MICA, MICB ubiquitylation of full-length MICA and targeting to
unknown compartment, downmodulation of MICB
[78]
HIV Nef MICA, ULBP-1, ULBP-2 downmodulation [79]
ZPXV soluble NKG2D ligands NKG2D saturation of receptor [35]
Interference with Ly49 receptors
MCMV m157 Ly49H, Ly49I ligand for activating Ly49H and inhibitory Ly49I
receptors
[27]
MCMV m04 Ly49P in complex with MHC I engages Ly49P and putative
inhibitory Ly49 receptor
[14]
Interference with natural cytotoxicity receptors
Influenza virus HA NKp30, NKp46 ζ-chain degradation in lysosomes [80]
HCMV pp65 NKp30 dissociation of ζ-chain from NKp30 [48]
Interference with other NK cell receptors
KSHV K5 AICL downregulation of NKp80 ligand AICL [78]
HCMV UL141 CD155 sequestration of CD155 in the ER, prevention of NK
cell activation via activating receptors CD96 and
DNAM-1
[52]
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